Welcome to LookChem.com Sign In|Join Free

CAS

  • or

205756-49-6

Post Buying Request

205756-49-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

205756-49-6 Usage

Type

Synthetic thyroid hormone

Structural Similarity

Similar to naturally occurring hormone thyroxine

Purpose

Treats hypothyroidism (low thyroid hormone production)

Mechanism of Action

Replaces missing hormone, regulates energy and metabolism

Form

Oral medication

Administration

Once a day on an empty stomach

Time to Effect

Full effects take several weeks

Side Effects

Hair loss, weight loss, tremors, irritability

Drug Interactions

May interact with other medications

Consultation

Important to consult healthcare professional before starting or stopping treatment

Check Digit Verification of cas no

The CAS Registry Mumber 205756-49-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,7,5 and 6 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 205756-49:
(8*2)+(7*0)+(6*5)+(5*7)+(4*5)+(3*6)+(2*4)+(1*9)=136
136 % 10 = 6
So 205756-49-6 is a valid CAS Registry Number.

205756-49-6Relevant articles and documents

Fluorescence "turn-on" sensing of carboxylate anions with oligothiophene-based o-(carboxamido)trifluoroacetophenones

Kim, Dae-Sik,Kyo, Han Ahn

, p. 6831 - 6834 (2008/12/22)

(Chemical Equation Presented) o-(Carboxamido)trifluoroacetophenones containing ter- or pentathiophene moiety as a fluorophore exhibit fluorescence enhancement upon binding carboxylate anions. Particularly, the terthiophene derivative shows a large fluorescence enhancement factor (FEF = 120). The enhancement is explained by intramolecular H-bonding stabilization of an anion-ionophore adduct, through which a possible quenching process, the n-π* transition from the trifluoroacetophenone moiety, is eliminated.

Electrophilic ketones for the treatment of herpesvirus infections

-

, (2008/06/13)

A class of compounds is described which can be used for the treatment of viral infections. Compounds of particular interest are defined by Formula II wherein each of R1, R2, and R3 is independently selected from hydrido, h

4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same

-

, (2008/06/13)

The present invention relates to benzoxazinones of formula I: STR1 or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as an assay standard or reagent, and intermediates and processes for making the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 205756-49-6